Decoy Therapeutics DCOY
NASDAQ DCOY
$1.97 -0.16 (-7.51%)
At close: Sep 30, 2026 · 4:00 PM EDT

Decoy Therapeutics (DCOY) Current Deferred Revenue (2016 - 2026)

Updated

Decoy Therapeutics (DCOY) posted Current Deferred Revenue of $3 million for Q2 2026, down 6.3% from the prior quarter.

Analysis

Decoy Therapeutics (DCOY) Current Deferred Revenue (2016 - 2026) Analysis & Trends

At the end of FY2025, Decoy Therapeutics' Current Deferred Revenue came in at $3.2 million.

  • The Q2 2026 figure stands as the lowest quarterly Current Deferred Revenue since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Decoy Therapeutics 1.05 Mn 1.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.00 Mn
Mar 31, 2026 3.20 Mn
Dec 31, 2025 3.20 Mn
Dec 31, 2019 541,701.00
Sep 30, 2019 1.58 Mn
Dec 31, 2018 4.01 Mn
Dec 31, 2017 72,188.00
Sep 30, 2017 97,571.00
Jun 30, 2017 96,667.00
Mar 31, 2017 80,637.00
Dec 31, 2016 88,344.00
Sep 30, 2016 81,399.00
Jun 30, 2016 65,115.00
API Access

Decoy Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DCOY&period=max&api_key=YOUR_API_KEY